These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34023160)

  • 1. Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk.
    Vakkalanka P; Lund BC; Arndt S; Field W; Charlton M; Ward MM; Carnahan RM
    Am J Prev Med; 2021 Sep; 61(3):418-427. PubMed ID: 34023160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment.
    Glanz JM; Binswanger IA; Clarke CL; Nguyen AP; Ford MA; Ray GT; Xu S; Hechter RC; Yarborough BJH; Roblin DW; Ahmedani B; Boscarino JA; Andrade SE; Rosa CL; Campbell CI
    Addiction; 2023 Jan; 118(1):97-107. PubMed ID: 35815386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
    Gomes T; McCormack D; Bozinoff N; Tadrous M; Antoniou T; Munro C; Campbell T; Paterson JM; Mamdani M; Sproule B
    Addiction; 2022 Jul; 117(7):1972-1981. PubMed ID: 35257434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
    Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
    Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
    Williams AR; Samples H; Crystal S; Olfson M
    Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study.
    Fine DR; Yu L; Triant VA; Baggett TP; Metlay JP
    J Gen Intern Med; 2020 Aug; 35(8):2375-2382. PubMed ID: 32206993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
    Bagley SM; Larochelle MR; Xuan Z; Wang N; Patel A; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY
    Ann Emerg Med; 2020 Jan; 75(1):29-38. PubMed ID: 31591014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.
    Bozinoff N; Men S; Kurdyak P; Selby P; Gomes T
    JAMA Netw Open; 2022 Sep; 5(9):e2234168. PubMed ID: 36173629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.
    Finlay AK; Harris AH; Rosenthal J; Blue-Howells J; Clark S; McGuire J; Timko C; Frayne SM; Smelson D; Oliva E; Binswanger I
    Drug Alcohol Depend; 2016 Mar; 160():222-6. PubMed ID: 26832998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of Medications for Opioid Use Disorder Across US States: Relationship to Treatment Availability and Overdose Mortality.
    Krawczyk N; Jent V; Hadland SE; Cerdá M
    J Addict Med; 2022 Jan-Feb 01; 16(1):114-117. PubMed ID: 35120067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes.
    Samples H; Williams AR; Crystal S; Olfson M
    J Subst Abuse Treat; 2022 Aug; 139():108774. PubMed ID: 35337716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose.
    Victor GA; Bailey K; Ray B
    Subst Use Misuse; 2021; 56(7):988-996. PubMed ID: 33749520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study.
    Larochelle MR; Liebschutz JM; Zhang F; Ross-Degnan D; Wharam JF
    Ann Intern Med; 2016 Jan; 164(1):1-9. PubMed ID: 26720742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.
    Fox L; Nelson LS
    CNS Drugs; 2019 Dec; 33(12):1147-1154. PubMed ID: 31552608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic relationships between Veterans and buprenorphine providers and effects on treatment retention.
    Vakkalanka JP; Lund BC; Arndt S; Field W; Charlton M; Ward MM; Carnahan RM
    Health Serv Res; 2022 Apr; 57(2):392-402. PubMed ID: 34854083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal System Involvement and Opioid-Related Overdose Mortality in U.S. Department of Veterans Affairs Patients.
    Finlay AK; Palframan KM; Stimmel M; McCarthy JF
    Am J Prev Med; 2022 Jan; 62(1):e29-e37. PubMed ID: 34521559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study.
    Abrahamsson T; Berge J; Öjehagen A; Håkansson A
    Drug Alcohol Depend; 2017 May; 174():58-64. PubMed ID: 28315808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.